Amyloid-beta interactions with ABC transporters and resistance modifiers

J. Molnár, I. Ocsovszki, Rozalia Pusztai

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background/Aim: Failure of cancer chemotherapy caused by multidrug resistance (MDR) of tumor cells is mediated by ABC transporters that reduce the uptake of cytotoxic agents. Similar transporters are responsible for amyloid clearance in nerve cells in Alzheimer’s disease (AD). The aim of this study was to compare the biological effects of amyloid complexes of some known ABC transporter inhibitors e.g. disiloxanes. One of the most active fragments of the pathological “endogen” substrate responsible for AD was investigated in the presence of amyloid-beta fragment on the reversal of multidrug resistance and apoptosis induction on multidrug-resistant tumor cells in model experiments. Materials and Methods: The efflux pump activity of the cells treated with amyloid-beta complexes was studied by Rhodamin-123 accumulation. Apoptosis induction was measured by staining of treated cells by Annexin-V and propidium iodine. The fluorescent activity FL-1 and FL-2 of the cells was measured and analyzed on a PARTEC FACScan instrument. Results: The resistance modifiers: disiloxanes and memantine complexed with amyloid-beta 1-42 reduced the activity of ABC transporter in MDR tumor cells. Early apoptosis was moderately increased by amyloid-beta complexes. Late apoptosis and the number of total viable cells were not changed. Conclusion: Amyloid-beta and its complexes inactivate the efflux pump of tumor cells resulting in accumulation of amyloid. It is supposed that reduced membrane transport can explain the lower incidence of cancer in AD.

Original languageEnglish
Pages (from-to)3407-3410
Number of pages4
JournalAnticancer Research
Volume38
Issue number6
DOIs
Publication statusPublished - Jun 1 2018

Fingerprint

ATP-Binding Cassette Transporters
Amyloid
Multiple Drug Resistance
Apoptosis
Neoplasms
Alzheimer Disease
Memantine
Propidium
Annexin A5
Cytotoxins
Iodine
Staining and Labeling
Neurons
Drug Therapy
Membranes
Incidence

Keywords

  • ABC transporter
  • Alzheimer’s disease
  • Amyloid-beta peptide
  • Amyloid-disiloxane complexes
  • Amyloid-memantine
  • Human MDR1 gene transfected mouse lymphoma cell

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Amyloid-beta interactions with ABC transporters and resistance modifiers. / Molnár, J.; Ocsovszki, I.; Pusztai, Rozalia.

In: Anticancer Research, Vol. 38, No. 6, 01.06.2018, p. 3407-3410.

Research output: Contribution to journalArticle

@article{3f9fcd74788d4e7484cee3974b07d150,
title = "Amyloid-beta interactions with ABC transporters and resistance modifiers",
abstract = "Background/Aim: Failure of cancer chemotherapy caused by multidrug resistance (MDR) of tumor cells is mediated by ABC transporters that reduce the uptake of cytotoxic agents. Similar transporters are responsible for amyloid clearance in nerve cells in Alzheimer’s disease (AD). The aim of this study was to compare the biological effects of amyloid complexes of some known ABC transporter inhibitors e.g. disiloxanes. One of the most active fragments of the pathological “endogen” substrate responsible for AD was investigated in the presence of amyloid-beta fragment on the reversal of multidrug resistance and apoptosis induction on multidrug-resistant tumor cells in model experiments. Materials and Methods: The efflux pump activity of the cells treated with amyloid-beta complexes was studied by Rhodamin-123 accumulation. Apoptosis induction was measured by staining of treated cells by Annexin-V and propidium iodine. The fluorescent activity FL-1 and FL-2 of the cells was measured and analyzed on a PARTEC FACScan instrument. Results: The resistance modifiers: disiloxanes and memantine complexed with amyloid-beta 1-42 reduced the activity of ABC transporter in MDR tumor cells. Early apoptosis was moderately increased by amyloid-beta complexes. Late apoptosis and the number of total viable cells were not changed. Conclusion: Amyloid-beta and its complexes inactivate the efflux pump of tumor cells resulting in accumulation of amyloid. It is supposed that reduced membrane transport can explain the lower incidence of cancer in AD.",
keywords = "ABC transporter, Alzheimer’s disease, Amyloid-beta peptide, Amyloid-disiloxane complexes, Amyloid-memantine, Human MDR1 gene transfected mouse lymphoma cell",
author = "J. Moln{\'a}r and I. Ocsovszki and Rozalia Pusztai",
year = "2018",
month = "6",
day = "1",
doi = "10.21873/anticanres.12608",
language = "English",
volume = "38",
pages = "3407--3410",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - Amyloid-beta interactions with ABC transporters and resistance modifiers

AU - Molnár, J.

AU - Ocsovszki, I.

AU - Pusztai, Rozalia

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Background/Aim: Failure of cancer chemotherapy caused by multidrug resistance (MDR) of tumor cells is mediated by ABC transporters that reduce the uptake of cytotoxic agents. Similar transporters are responsible for amyloid clearance in nerve cells in Alzheimer’s disease (AD). The aim of this study was to compare the biological effects of amyloid complexes of some known ABC transporter inhibitors e.g. disiloxanes. One of the most active fragments of the pathological “endogen” substrate responsible for AD was investigated in the presence of amyloid-beta fragment on the reversal of multidrug resistance and apoptosis induction on multidrug-resistant tumor cells in model experiments. Materials and Methods: The efflux pump activity of the cells treated with amyloid-beta complexes was studied by Rhodamin-123 accumulation. Apoptosis induction was measured by staining of treated cells by Annexin-V and propidium iodine. The fluorescent activity FL-1 and FL-2 of the cells was measured and analyzed on a PARTEC FACScan instrument. Results: The resistance modifiers: disiloxanes and memantine complexed with amyloid-beta 1-42 reduced the activity of ABC transporter in MDR tumor cells. Early apoptosis was moderately increased by amyloid-beta complexes. Late apoptosis and the number of total viable cells were not changed. Conclusion: Amyloid-beta and its complexes inactivate the efflux pump of tumor cells resulting in accumulation of amyloid. It is supposed that reduced membrane transport can explain the lower incidence of cancer in AD.

AB - Background/Aim: Failure of cancer chemotherapy caused by multidrug resistance (MDR) of tumor cells is mediated by ABC transporters that reduce the uptake of cytotoxic agents. Similar transporters are responsible for amyloid clearance in nerve cells in Alzheimer’s disease (AD). The aim of this study was to compare the biological effects of amyloid complexes of some known ABC transporter inhibitors e.g. disiloxanes. One of the most active fragments of the pathological “endogen” substrate responsible for AD was investigated in the presence of amyloid-beta fragment on the reversal of multidrug resistance and apoptosis induction on multidrug-resistant tumor cells in model experiments. Materials and Methods: The efflux pump activity of the cells treated with amyloid-beta complexes was studied by Rhodamin-123 accumulation. Apoptosis induction was measured by staining of treated cells by Annexin-V and propidium iodine. The fluorescent activity FL-1 and FL-2 of the cells was measured and analyzed on a PARTEC FACScan instrument. Results: The resistance modifiers: disiloxanes and memantine complexed with amyloid-beta 1-42 reduced the activity of ABC transporter in MDR tumor cells. Early apoptosis was moderately increased by amyloid-beta complexes. Late apoptosis and the number of total viable cells were not changed. Conclusion: Amyloid-beta and its complexes inactivate the efflux pump of tumor cells resulting in accumulation of amyloid. It is supposed that reduced membrane transport can explain the lower incidence of cancer in AD.

KW - ABC transporter

KW - Alzheimer’s disease

KW - Amyloid-beta peptide

KW - Amyloid-disiloxane complexes

KW - Amyloid-memantine

KW - Human MDR1 gene transfected mouse lymphoma cell

UR - http://www.scopus.com/inward/record.url?scp=85048235712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048235712&partnerID=8YFLogxK

U2 - 10.21873/anticanres.12608

DO - 10.21873/anticanres.12608

M3 - Article

VL - 38

SP - 3407

EP - 3410

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6

ER -